Two of my studies ('EUPAS31001: Valproate drug utilisation study after the 2018 EU risk minimisation measures', and 'EUPAS44970: Risk awareness and adherence with regulatory communication on TTS and SARS-CoV-2 adenovirus vaccines') mentioned in the 'Report on pharmacovigilance tasks from EU Member States and the European Medicines Agency (EMA) 2019-2022' - European Medicines Agency (EMA) (22-06-2023)
Interview as part of a Journal Watch by Doctors.net.uk regarding my PhD study on 'Low-dose oral glucocorticoids and risk of osteoporotic fractures in patients with rheumatoid arthritis' - Doctors.net.uk, the largest UK Doctors association (06-06-2022)
2021
Vertebral fractures still a risk with low-dose oral glucocorticoids for RA - MDEdge Medscape / Rheumatology (20-07-2021)